Cowen analyst Chris Shibutani lowered the price target on Puma Biotechnology (NASDAQ: PBYI) to $41.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE